Erik Hahn is currently the Associate Director of Clinical Pharmacology in Oncology at Pfizer. With a background as a clinical pharmacologist and pharmacometrician, Erik has successfully contributed to multiple (s)NDAs by implementing model-informed drug development. Previously, Erik held roles at Array BioPharma Inc. as a Pharmacokineticist, where they supported clinical study design and regulatory submissions. Erik earned a Bachelor of Arts in Biology and Philosophy from Luther College and a Master of Science in Pharmacometrics from the University of Maryland School of Pharmacy.
This person is not in any teams
This person is not in any offices